Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts
  • Log out

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
  • Log out
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Review ArticleClinical Review

Lead and children

Clinical management for family physicians

Alan R. Abelsohn and Margaret Sanborn
Canadian Family Physician June 2010; 56 (6) 531-535;
Alan R. Abelsohn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alan.abelsohn@utoronto.ca
Margaret Sanborn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • CFPlus
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE To provide family physicians with a practical, evidence-based approach to screening for and preventing children’s exposure to lead.

SOURCES OF INFORMATION MEDLINE was searched using terms relevant to lead exposure and poisoning. We reviewed English-language articles published in 2003 to 2008. Most cited studies provide level 2 or 3 evidence.

MAIN MESSAGE Lead is a developmental neurotoxin. Children are most commonly exposed and they are most vulnerable. Lead exposure has been associated with many cognitive and motor deficits, as well as distractibility and other characteristics of attention deficit hyperactivity disorder. Although children’s blood lead levels have declined considerably over the past 3 decades with removal of lead from gasoline and paint, children can still be exposed to lead from lead paint in older homes, toys, and other sources. Because post-exposure treatment cannot reverse the cognitive effects of lead exposure, preventing lead exposure is essential.

CONCLUSION Family physicians have an important role in screening for children at high risk of lead exposure, and in educating families to prevent the exposure of children to lead.

During a 1-year well-baby checkup, John’s mother asks whether lead might be affecting her son. She has heard about lead in drinking water and children’s toys. Questioning reveals that they live in a 1920s house and have been renovating for a year. The front porch, where the paint is in poor condition, has yet to be renovated. The house has original plumbing and the family drinks unfiltered municipal tap water. John is healthy and is growing and developing normally.

How should John’s mother be counseled? Are any tests or follow-up visits required? We discuss possible sources of lead exposure for Canadian children, lead toxicity to children, and a prevention and management approach for family physicians.

Health effects of lead

Lead is a developmental neurotoxin, interfering with neurotransmission, cellular migration, and synaptic plasticity during central nervous system development.1 Children are more vulnerable than adults to the effects of lead for several reasons: they are exposed more often by hand-mouth behaviour and spend time on dusty floors; they absorb lead more efficiently from the gastrointestinal tract (40% vs 5% to 15% for adults),2 a capacity increased by concurrent iron or calcium deficiency1; and their blood-brain barrier and liver detoxification systems are biologically immature.1

Exposure to lead has been associated with many cognitive and motor deficits (eg, deficiencies in reading and math skills, fine and gross motor skills, and memory) and distractibility and other characteristics of attention deficit hyperactivity disorder.3–6 Epidemiologic studies show associations between even low blood lead levels (BLLs) and lowered intelligence quotient (IQ).5

Higher BLLs (and higher lead body burdens measured by levels in bones and teeth) are associated with adolescent delinquent behaviour, poor educational outcomes, reduced adult brain volume, and increased criminal arrests.5,7–11 Clinical symptoms such as anemia, abdominal pain, or neurologic deficits are rare and occur only at very high BLLs. Because lead crosses the placenta and accumulates in fetal tissue, fetuses are especially vulnerable to lead-related neurologic injury.12

Measuring BLLs is the best available way to determine lead exposure. Measuring BLLs accurately reflects recent exposures but poorly captures the cumulative body burden. There is no practical, clinically available measure of lead body burden.13,14

Blood lead levels are measured and reported differently in Canada and the United States (Table 1). The US Centers for Disease Control and Prevention (CDC) action level for blood lead is 10 μg/dL (0.48 μmol/L). This level has been recently questioned, because many recent studies demonstrate neurodevelopmental effects below 10 μg/dL, with no lower threshold for injury identified, suggesting that the decline rate (dose-response curve) in IQ scores might be greater at lower doses.1,5,8,15–18

View this table:
  • View inline
  • View popup
Table 1.

Measurement of blood lead levels in Canada and the United States

Sources of information

In preparing this article, we searched MEDLINE using terms relevant to lead exposure and poisoning. We reviewed English-language articles published in 2003 to 2008. Most cited studies provide level 2 or 3 evidence.

Home sources of lead exposure

In the United States, 70% of children’s lead exposure is from lead-based paint in the home.19 In Canada, rental housing and paint surfaces are better maintained than in the United States, resulting in less lead exposure. Lead was eliminated from all paint in Canada in 1991, and Canadian regulations have limited concentrations in interior paint since 1978. Half of Canadian dwellings predate 1970 and would still have lead paint,20 likely covered by lead-free paint. Lead is liberated in dust or chips from paint in poor repair, or during renovation activities including sanding or heat-stripping; children are exposed by ingesting lead-containing paint dust or chips. Children with developmental delays are at higher risk of lead ingestion and are more likely to present with lead poisoning after age 3.1

The remaining 30% of elevated BLLs in US children are from nonpaint sources,19 including soil around homes (from exterior paint, nearby highways, or industries), toys, food, and herbal products. Recently, many children’s toys, including brands such as Thomas and Friends Wooden Railway, Batman, and Dora the Explorer, have been withdrawn from the market because of high lead content, usually in the paint. Any recalled toys should be discarded. Food is a less common source, but lead-soldered pots or lead-containing glazed pottery and crystal glassware occasionally contaminate food.21 Lead sources are listed in Table 2.1,13

View this table:
  • View inline
  • View popup
Table 2.

Sources of childhood lead poisoning

Childhood lead exposure from drinking water has been in the news recently.22,23 Drinking water in many older Canadian homes and schools with original plumbing contains lead, which leaches from lead service connection pipes outside the home and lead-soldered plumbing inside the home. Lead pipes were used in “well-built” homes until the 1920s, and 50%-lead solder was used until the late 1980s.24 Although lead in drinking water can occasionally cause serious exposure,23 its levels are generally low.22,24 Tests for lead in water can be done through public health units or private water testing companies.25

Public health interventions, such as removing lead from gasoline, paint, plumbing supplies, and food and drink cans, have successfully reduced children’s BLLs. The percentage of US children with BLLs above 0.48 μmol/L (10 μg/dL) dropped from 77.8% to 1.6% between 1980 and 2002.1 Less than 1% of adult Canadians have BLLs above 0.48 μmol/L (10 μg/dL).26 No population-based data are available for Canadian children younger than age 6; children in only 3 communities having been studied. Children in Vancouver, BC, were found to have a mean BLL of 0.29 μmol/L in 1989; 8% of this sample had levels greater than 0.48 μmol/L.27 Emissions from a large lead-zinc smelter in Trail, BC, contaminated local air and soil, raising childhood BLLs; a childhood lead-exposure prevention program, in which improved technology reduced smelter emissions, reduced children’s mean BLLs to 0.28 μmol/L (5.9 μg/dL) by 1999.28 A small study of 5-year-old Inuit children from Nunavik showed mean BLLs of 0.26 μmol/L (5.3 μg/dL).3

Immigrant or adopted children from countries with higher endemic lead exposures might have elevated BLLs and should be considered to be high risk. Information on high-risk countries can be found in the CDC tool kit, CDC Lead Poisoning Prevention in Newly Arrived Refugee Children.29

Screening

Because post-exposure treatment cannot reverse the cognitive effects of lead exposure, prevention is essential. The Rourke Baby Record recommends screening questions for lead exposure at 12 months and 2 years of age (Box 1).30

The CDC criteria for high-risk groups meriting screening include those identified by the first 3 Rourke Baby Record questions (although the cutoff date for housing is 1978) but add the following:

  • children living near lead smelting or processing plants, battery recycling facilities, or other point sources of lead contamination;

  • children having parents or other household members with lead-related occupations or lead-related hobbies (eg, pottery and furniture refinishing); and

  • all refugee children aged 6 months to 6 years, within 3 months of arrival and again in 3 to 6 months.29

Box 1.

Screening for lead exposure with the Rourke Baby Record

Lead screening is recommended for children who ...
  • in the past 6 months lived in a house or apartment built before 1950,

  • live in a house with recent or ongoing renovations or peeling or chipped paint,

  • have a sibling, housemate, or playmate with previous history of lead poisoning, or

  • have been seen eating paint chips.

  • Data from Rourke et al.30

  • There are no Canadian screening guidelines, although in 1995 the Canadian Task Force on Preventive Health Care found fair evidence supporting targeted screening in high-risk children and infants (B recommendation), but insufficient evidence to recommend for or against universal screening (C recommendation).31

    Screening questions have some limitations. All 4 questions in the Rourke version target the 70% of children whose lead exposure comes from household paint. The US version was validated in a suburban population, and the questions might not be generalizable to other groups or regions.32

    Office approach to prevention

    During preconception counseling, antenatal appointments, or well-baby checkups, family physicians can educate parents about avoiding lead-exposure risks. A patient handout on protecting children from lead is available from CFPlus.*

    Preconception detection

    Preconception detection of elevated maternal BLLs is vital to primary prevention. Women in occupations or who have hobbies with high lead exposure are at risk.1 Studies correlating elevated cord BLLs with impaired child neurodevelopment provide direct evidence that preventing lead exposure during pregnancy is important.5,12,33 A modest 11% reduction in maternal BLLs was achieved in a randomized controlled trial of maternal supplementation with 1200 mg of calcium throughout pregnancy; if more than 75% of prescribed calcium doses were taken, there was a 24% reduction in BLLs.34 The same dose of calcium during lactation reduced maternal BLLs by 15% to 20%35 and increased the decline in breast milk lead by 5% to 10%.36

    Preventing lead paint exposure

    Screening infants and toddlers 9 to 18 months of age is encouraged, using screening questions and measuring BLLs when indicated. However, more benefit is obtained from primary prevention questioning and education of prospective parents about their housing, state of repair of paint, and renovation activities before their children’s birth.

    Drinking water

    In homes, schools, and day-care centres with older plumbing, letting water run for 5 minutes or more until it is cold before drinking eliminates standing water that has been in contact with the lead in pipes, reducing ingested lead.22

    High-risk children

    Children with developmental delays such as autism spectrum disorder and pervasive developmental delay constitute a high-risk group whose persistent hand-mouth behaviour carries risk of lead poisoning beyond the usual 18- to 30-month peak.1,37 Accordingly, family physician inquiry and screening of lead levels in older children with these diagnoses might be useful.

    Case discussion and management

    In our case, the child met 2 risk factors for higher lead-exposure risk: he lived in an old house with peeling paint on the porch, and renovations were in progress. John’s BLL was measured; the result was 0.576 μmol/L (12 μg/dL). This is above the previously recognized “action” level of 0.48 μmol/L (10 μg/dL), and more recent evidence suggests there is no safe BLL.

    What should be done?

    John’s BLL should be retested immediately to confirm the results, and complete blood count and ferritin levels should be tested to rule out iron deficiency.14

    A careful exposure history38 should be taken to rule out nonpaint lead exposures. In this case, the only source of lead exposure was high-lead paint, applied before 1978, liberated by interior renovations and in deteriorating condition on the porch. Hand-mouth activity, with ingestion of lead in dust, was the exposure route for this child.

    To prevent continuing exposure, John must immediately be removed from the home until the home has been cleaned up or the situation has abated.1 The Canada Mortgage and Housing Corporation provides careful advice on work-site cleanup and managing deteriorating paint.24 Public health inspectors can perform home inspections and dust-wipe testing to confirm dust as a source of lead exposure.

    If the child is iron deficient, iron supplementation (4 to 6 mg/kg daily) can be neuroprotective by reducing gastrointestinal lead absorption. Calcium and zinc supplementation might also be indicated.1

    Chelation to decrease BLLs by promoting urinary lead excretion is not indicated for BLLs below 2.16 μmol/L (45 μg/dL)1,39 and should only be done by pediatricians experienced in such treatment. Blood lead levels naturally decline over time, but the half-life is long and variable.14

    Neuropsychological evaluation and follow-up is suggested for children with levels exceeding 0.96 μmol/L (20 μg/dL).1

    Conclusion

    There is a long history of progressive reductions of the BLLs in children requiring action, as research has extended the levels associated with poor developmental outcomes ever lower. New research showing considerable neurodevelopmental effects at BLLs well below 0.48 μmol/L (10 μg/dL), the current “level of concern,”14 and the importance of preventing exposure have led to debate about further reducing the level of concern to 0.24 μmol/L (5 μg/dL) or even 0.10 μmol/L (2 μg/dL).5,40–42 A new action level of 0.24 μmol/L (5 μg/dL) has been proposed in the United States. It was estimated this change would reclassify 7.3% of children aged 1 to 5 and 2.8% aged 6 to 11 with BLLs of 0.24 to 0.48 μmol/L (5.0 to 9.9 μg/dL) to a group requiring evaluation and treatment,42 creating new health care and housing remediation expenses. However, there is a powerful economic argument for lowering lead action levels: lower IQs associated with lead exposure are strong indicators of future lost earning power and antisocial behaviour.11,43

    Because the interventions that reduce high BLLs have not been proven effective in preventing neurocognitive deficits, screening is considered too little too late. Preventing exposure through office-based and public education about the hazards of lead exposure is optimal.

    Notes

    EDITOR’S KEY POINTS

    • Lead is a developmental neurotoxin, interfering with neurotransmission, cellular migration, and synaptic plasticity during central nervous system development. Epidemiologic studies show associations between even low blood lead levels and lowered intelligence quotient.

    • Interventions that reduce high blood lead levels have not been proven effective for preventing neurocognitive deficits; as a result, screening is considered too little too late. Preventing exposure through office-based and public education about the hazards of lead exposure is optimal.

    • During preconception counseling, antenatal appointments, or well-baby checkups, family physicians can educate parents about avoiding lead-exposure risks.

    POINTS DE REPÈRE DU RÉDACTEUR

    • Le plomb est une neurotoxine qui agit sur le développement en interférant avec la neurotransmission, la migration cellulaire et la plasticité synaptique au cours du développement du système nerveux central. Les études épidémiologiques indiquent une association entre un faible quotient intellectuel et la présence de plomb dans le sang, même à des niveaux faibles.

    • On n’a pas démontré que les interventions pour réduire les niveaux élevés de plomb dans le sang sont efficaces pour prévenir les déficits cognitifs; en conséquence, on juge que le dépistage est « trop peu trop tard ». La meilleure façon de prévenir l’exposition au plomb consiste à renseigner la population sur ses dangers, tant au bureau du médecin que dans les services publics.

    • Lors des consultations antérieures à la conception, des visites prénatales ou du suivi du nouveau-né, le médecin de famille peut montrer aux parents comment éviter les risques d’exposition au plomb.

    Footnotes

    • This article is eligible for Mainpro-M1 credits. To earn credits, go to www.cfp.ca and click on the Mainpro link.

    • This article has been peer reviewed.

    • Cet article a fait l’objet d’une révision par des pairs.

    • ↵* A patient handout on protecting children from lead exposure is available at www.cfp.ca. Go to the full text of the article online, then click on CFPlus in the menu at the top right of the page.

    • Contributors

      Drs Abelsohn and Sanborn contributed to the literature search and preparation of the article.

    • Competing interests

      None declared

    • Copyright© the College of Family Physicians of Canada

    References

    1. ↵
      1. Woolf AD,
      2. Goldman R,
      3. Bellinger DC
      . Update on the clinical management of childhood lead poisoning. Pediatr Clin North Am 2007;54(2):271-94, viii.
      OpenUrlCrossRefPubMed
    2. ↵
      1. Ziegler EE,
      2. Edwards BB,
      3. Jensen RL,
      4. Mahaffey KR,
      5. Fomon SJ
      . Absorption and retention of lead by infants. Pediatr Res 1978;12(1):29-34.
      OpenUrlCrossRefPubMed
    3. ↵
      1. Fraser S,
      2. Muckle G,
      3. Després C
      . The relationship between lead exposure, motor function and behaviour in Inuit preschool children. Neurotoxicol Teratol 2006;28(1):18-27. Epub 2005 Dec 5.
      OpenUrlPubMed
      1. Banerjee TD,
      2. Middleton F,
      3. Faraone SV
      . Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 2007;96(9):1269-74.
      OpenUrlCrossRefPubMed
    4. ↵
      1. Bellinger DC
      . Very low lead exposures and children’s neurodevelopment. Curr Opin Pediatr 2008;20(2):172-7.
      OpenUrlCrossRefPubMed
    5. ↵
      1. Nigg JT,
      2. Knottnerus GM,
      3. Martel MM,
      4. Nikolas M,
      5. Cavanagh K,
      6. Karmaus W,
      7. et al
      . Low blood lead levels associated with clinically diagnosed attention-deficit disorder/hyperactivity disorder and mediated by weak cognitive control. Biol Psychiatry 2008;63(3):325-31. Epub 2007 Sep 14.
      OpenUrlCrossRefPubMed
    6. ↵
      1. Chen A,
      2. Cai B,
      3. Dietrich KN,
      4. Radcliffe J,
      5. Rogan WJ
      . Lead exposure, IQ, and behavior in urban 5- to 7-year-olds: does lead affect behavior only by lowering IQ? Pediatrics 2007;119(3):e650-8.
      OpenUrlAbstract/FREE Full Text
    7. ↵
      1. Téllez-Rojo MM,
      2. Bellinger DC,
      3. Arroyo-Quiroz C,
      4. Lamadrid-Figueroa H,
      5. Mercado-Garcia A,
      6. Schnaas-Arrieta L,
      7. et al
      . Longitudinal associations between blood lead concentrations lower than 10 μg/dL and neurobehavioral development in environmentally exposed children in Mexico City. Pediatrics 2006;118(2):e323-30.
      OpenUrlAbstract/FREE Full Text
      1. Centers for Disease Control and Prevention (CDC) Advisory Committee on Childhood Lead Poisoning Prevention
      . Interpreting and managing blood lead levels < 10 μg/dL in children and reducing childhood exposures to lead: recommendations of CDC’s Advisory Committee on Childhood Lead Poisoning Prevention. MMWR Recomm Rep 2007;56(RR-8):1-16. Erratum in: MMWR Morbid Mortal Wkly Rep 2007;56(47):1241.
      OpenUrlPubMed
      1. Cecil KM,
      2. Brubaker CJ,
      3. Adler CM,
      4. Dietrich KN,
      5. Altaye M,
      6. Egelhoff J,
      7. et al
      . Decreased brain volume in adults with childhood lead exposure. PLoS Med 2008;5(5):e112.
      OpenUrlCrossRefPubMed
    8. ↵
      1. Wright JP,
      2. Dietrich KN,
      3. Ris MD,
      4. Hornung RW,
      5. Wessel SD,
      6. Lanphear BP,
      7. et al
      . Association of prenatal and childhood blood lead concentrations with criminal arrests in early adulthood. PLoS Med 2008;5(5):e101.
      OpenUrlCrossRefPubMed
    9. ↵
      1. Ronchetti R,
      2. van den Hazel P,
      3. Schoeters G,
      4. Hanke W,
      5. Rennezova Z,
      6. Barreto M,
      7. et al
      . Lead neurotoxicity in children: is prenatal exposure more important than postnatal exposure? Acta Paediatr Suppl 2006;95(453):45-9.
      OpenUrlPubMed
    10. ↵
      1. Brodkin E,
      2. Copes R,
      3. Mattman A,
      4. Kennedy J,
      5. Kling R,
      6. Yassi A
      . Lead and mercury exposures: interpretation and action. CMAJ 2007;176(1):59-63.
      OpenUrlAbstract/FREE Full Text
    11. ↵
      1. Binns HJ,
      2. Campbell C,
      3. Brown MJ,
      4. Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention
      . Interpreting and managing blood lead levels of less than 10 μg/dl in children and reducing childhood exposure to lead: recommendations of the Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention. Pediatrics 2007;120(5):e1285-98.
      OpenUrlAbstract/FREE Full Text
    12. ↵
      1. Canfield RL,
      2. Henderson CR Jr.,
      3. Cory-Slechta DA,
      4. Cox C,
      5. Jusko TA,
      6. Lanphear BP
      . Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. N Engl J Med 2003;348(16):1517-26.
      OpenUrlCrossRefPubMed
      1. Bellinger DC
      . Lead. Pediatrics 2004;113(4 Suppl):1016-22.
      OpenUrlAbstract/FREE Full Text
      1. Lanphear BP,
      2. Dietrich KN,
      3. Auinger P,
      4. Cox C
      . Cognitive deficits associated with blood lead concentrations <10 μg/dL in US children and adolescents. Public Health Rep 2000;115(6):521-9.
      OpenUrlCrossRefPubMed
    13. ↵
      1. Lanphear BP,
      2. Hornung R,
      3. Khoury J,
      4. Yolton K,
      5. Baghurst P,
      6. Bellinger DC,
      7. et al
      . Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ Health Perspect 2005;113(7):894-9.
      OpenUrlCrossRefPubMed
    14. ↵
      1. Levin R,
      2. Brown MJ,
      3. Kashtock ME,
      4. Jacobs DE,
      5. Whelan EA,
      6. Rodman J,
      7. et al
      . Lead exposures in U.S. children, 2008: implications for prevention. Environ Health Perspect 2008;116(10):1285-93. Epub 2008 May 19. Erratum in: Environ Health Perspect 2008;116(10)1291.
      OpenUrlPubMed
    15. ↵
      1. Statistics Canada
      . The economy. Manufacturing and construction. Canada e-book. Ottawa, ON: Statistics Canada; 2004. Available from: http://epe.lac-bac.gc.ca/100/205/301/statcan/canada_e-book-ef/05-01-21/142.206.72.67/03/03c/03c_000_e.htm. Accessed 2010 Apr 22.
    16. ↵
      1. Gorospe EC,
      2. Gerstenberger SL
      . Atypical sources of lead poisoning in the United States: a systematic review from 1966–2006. Clin Toxicol (Phila) 2008;46(8):728-37.
      OpenUrlCrossRefPubMed
    17. ↵
      1. Payne M
      . Lead in drinking water. CMAJ 2008;179(3):253-4.
      OpenUrlFREE Full Text
    18. ↵
      1. Edwards M,
      2. Triantafyllidou S,
      3. Best D
      . Elevated blood lead in young children due to lead-contaminated drinking water: Washington, DC, 2001–2004. Environ Sci Technol 2009;43(5):1618-23.
      OpenUrlPubMed
    19. ↵
      1. Canada Mortgage and Housing Corporation
      . Lead in your home. Ottawa, ON: Canada Mortgage and Housing Corporation, Health Canada; 2004. Available from: www.cmhc-schl.gc.ca/odpub/pdf/61941.pdf. Accessed 2009 Jun 9.
    20. ↵
      1. Canada Mortgage and Housing Corporation
      . Lead in older homes. Ottawa, ON: Canada Mortgage and Housing Corporation; 2009. Available from: www.cmhc-schl.gc.ca/en/co/maho/yohoyohe/inaiqu/inaiqu_007.cfm. Accessed 2009 Nov 29.
    21. ↵
      1. Statistics Canada
      . Canadian Health Measures Survey preliminary release— biomonitoring results of lead, mercury, and cadmium. Ottawa, ON: Statistics Canada; 2010. Available from: www.chemicalsubstanceschimiques.gc.ca/media/chms-eng.php. Accessed 2010 May 5.
    22. ↵
      1. Jin A,
      2. Hertzman C,
      3. Peck SH,
      4. Lockitch G
      . Blood lead levels in children aged 24 to 36 months in Vancouver. CMAJ 1995;152(7):1077-86.
      OpenUrlAbstract
    23. ↵
      1. Hilts SR
      . Effect of smelter emission reductions on children’s blood lead levels. Sci Total Environ 2003;303(1–2):51-8.
      OpenUrlPubMed
    24. ↵
      1. Centers for Disease Control
      . CDC lead poisoning prevention in newly arrived refugee children: tool kit. Atlanta, GA: Centers for Disease Control; 2009. Available from: www.cdc.gov/nceh/lead/Publications/RefugeeToolKit/Refugee_Tool_Kit.htm. Accessed 2009 Jun 9.
    25. ↵
      1. Rourke L,
      2. Rourke J,
      3. Leduc D
      . Rourke Baby Record: evidence-based infant/child care health maintenance guide [website]. St John’s, NL: Memorial University of Newfoundland; 2006. Available from: www.rourkebabyrecord.ca. Accessed 2009 Jun 9.
    26. ↵
      1. Feldman W,
      2. Randel P
      . Canadian guide to clinical preventive health care. Ottawa, ON: Health Canada; 1994. Screening children for lead exposure in Canada. In: Canadian Task Force on the Periodic Health Examination; p. 268-88.
    27. ↵
      1. Nordin JD,
      2. Rolnick S,
      3. Grifin JM
      . Prevalence of excess lead absorption and associated risk factors in children enrolled in a midwestern health maintenance organization. Pediatrics 1994;93(2):172-7.
      OpenUrlAbstract/FREE Full Text
    28. ↵
      1. Hu H,
      2. Téllez-Rojo MM,
      3. Bellinger D,
      4. Smith D,
      5. Ettinger AS,
      6. Lamadrid-Figueroa H,
      7. et al
      . Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect 2006;114(11):1730-5.
      OpenUrlPubMed
    29. ↵
      1. Ettinger AS,
      2. Lamadrid-Figueroa H,
      3. Téllez-Rojo MM,
      4. Mercado-Garcia A,
      5. Peterson KE,
      6. Schwartz J,
      7. et al
      . Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial. Environ Health Perspect 2009;117(1):26-31. Epub 2008 Sep 2.
      OpenUrlPubMed
    30. ↵
      1. Ettinger AS,
      2. Téllez-Rojo MM,
      3. Amarasiriwardena C,
      4. Peterson KE,
      5. Schwartz J,
      6. Aro A,
      7. et al
      . Influence of maternal bone lead burden and calcium intake on levels of lead in breast milk over the course of lactation. Am J Epidemiol 2006;163(1):48-56. Epub 2005 Dec 9.
      OpenUrlAbstract/FREE Full Text
    31. ↵
      1. Hernandez-Avila M,
      2. Gonzalez-Cossio T,
      3. Hernandez-Avila JE,
      4. Romieu I,
      5. Peterson KE,
      6. Aro A,
      7. et al
      . Dietary calcium supplements to lower blood lead levels in lactating women: a randomized placebo-controlled trial. Epidemiology 2003;14(2):206-12.
      OpenUrlCrossRefPubMed
    32. ↵
      1. Shannon M,
      2. Graef JW
      . Lead intoxication in children with pervasive developmental disorders. J Toxicol Clin Toxicol 1996;34(2):177-81.
      OpenUrlPubMed
    33. ↵
      1. Marshall L,
      2. Weir E,
      3. Abelsohn A,
      4. Sanborn MD
      . Identifying and managing adverse environmental health effects: 1. Taking an exposure history. CMAJ 2002;166(8):1049-55.
      OpenUrlAbstract/FREE Full Text
    34. ↵
      1. Gracia RC,
      2. Snodgrass WR
      . Lead toxicity and chelation therapy. Am J Health Syst Pharm 2007;64(1):45-53.
      OpenUrlAbstract/FREE Full Text
    35. ↵
      1. American Academy of Pediatrics Committee on Environmental Health
      . Lead exposure in children: prevention, detection, and management. Pediatrics 2005;116(4):1036-46.
      OpenUrlAbstract/FREE Full Text
      1. Gilbert SG,
      2. Weiss B
      . A rationale for lowering the blood lead action level from 10 to 2 μg/dL. Neurotoxicology 2006;27(5):693-701. Epub 2006 Aug 4.
      OpenUrlCrossRefPubMed
    36. ↵
      1. Iqbal S,
      2. Muntner P,
      3. Batuman V,
      4. Rabito FA
      . Estimated burden of blood lead levels 5 μg/dl in 1999–2002 and declines from 1988 to 1994. Environ Res 2008;107(3):305-11. Epub 2008 Mar 12.
      OpenUrlPubMed
    37. ↵
      1. Salkever DS
      . Updated estimates of earnings benefits from reduced exposure of children to environmental lead. Environ Res 1995;70(1):1-6.
      OpenUrlPubMed
    PreviousNext
    Back to top

    In this issue

    Canadian Family Physician: 56 (6)
    Canadian Family Physician
    Vol. 56, Issue 6
    1 Jun 2010
    • Table of Contents
    • About the Cover
    • Index by author
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Lead and children
    (Your Name) has sent you a message from The College of Family Physicians of Canada
    (Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Lead and children
    Alan R. Abelsohn, Margaret Sanborn
    Canadian Family Physician Jun 2010, 56 (6) 531-535;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Respond to this article
    Share
    Lead and children
    Alan R. Abelsohn, Margaret Sanborn
    Canadian Family Physician Jun 2010, 56 (6) 531-535;
    Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Health effects of lead
      • Sources of information
      • Home sources of lead exposure
      • Screening
      • Office approach to prevention
      • Case discussion and management
      • What should be done?
      • Conclusion
      • Notes
      • Footnotes
      • References
    • Figures & Data
    • CFPlus
    • eLetters
    • Info & Metrics
    • PDF

    Related Articles

    • PubMed
    • Google Scholar

    Cited By...

    • Routine paediatric lead screening questionnaires may not fully capture current risk factors
    • Releve postnatal Rourke 2017: Mise a jour clinique en matiere de soins preventifs chez les enfants de 5 ans et moins
    • Rourke Baby Record 2017: Clinical update for preventive care of children up to 5 years of age
    • Les bons conseils de la naissance a la maternelle: Quoi de neuf dans le Releve postnatal Rourke?
    • Getting it right from birth to kindergarten: What's new in the Rourke Baby Record?
    • Bone lead measurement
    • Response
    • Google Scholar

    More in this TOC Section

    • Top studies of 2024 relevant to primary care
    • Approach to steatotic liver disease in the office
    • Foreskin care
    Show more Clinical Review

    Similar Articles

    Navigate

    • Home
    • Current Issue
    • Archive
    • Collections - English
    • Collections - Française

    For Authors

    • Authors and Reviewers
    • Submit a Manuscript
    • Permissions
    • Terms of Use

    General Information

    • About CFP
    • About the CFPC
    • Advertisers
    • Careers & Locums
    • Editorial Advisory Board
    • Subscribers

    Journal Services

    • Email Alerts
    • Twitter
    • LinkedIn
    • Instagram
    • RSS Feeds

    Copyright © 2025 by The College of Family Physicians of Canada

    Powered by HighWire